Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: India's Jubilant Life Sciences Dec-Qtr Consol Net Profit Rises

Feb 5 (Reuters) - Jubilant Life Sciences Ltd  JULS.NS :
    * DEC-QUARTER CONSOL NET PROFIT 3.1 BILLION RUPEES VERSUS
2.03
BILLION RUPEES YEAR AGO
    * DEC-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 17.71
BILLION
RUPEES VERSUS 15.18 BILLION RUPEES YEAR AGO
    * COVID-19 NOT LIKELY TO HAVE MATERIAL IMPACT ON PERFORMANCE
DURING FY21
    * FOR LSI, SEES CLOSE TO DOUBLE-DIGIT REVENUE GROWTH,
SIGNIFICANT
EBITDA GROWTH IN FY21
    * OVERALL, CONTINUE TO SEE STRONG PERFORMANCE IN Q4FY21

Source text for Eikon:  ID:nBSE9psSLT 
Further company coverage:  JULS.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Jubilant Pharmova

See all news